Alfasigma Schweiz AG
Alfasigma Schweiz AG is a Originators company based in Zofingen (Aargau) recorded by Swissmedic as the authorisation holder for 11 human medicines. That places it 132 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Zofingen |
| Canton | Aargau |
| Authorisation holder | Yes |
| Medicines | 11 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | Alfasigma S.p.A. |
| Activity | Not available |
| Website | ch.alfasigma.com |
Medicines authorised in Switzerland
Alfasigma Schweiz AG is recorded by Swissmedic as the authorisation holder for 11 human medicines. The table shows 11 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
11 of 11 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Betnesol | 30120 | B | H02AB01 | 1963-09-24 |
| Carnitene | 47597 | B | A16AA01 | 1987-02-25 |
| Carnitene | 48509 | B | A16AA01 | 1987-10-30 |
| Carnitene 1 g/10 ml | 48508 | B | A16AA01 | 1988-08-29 |
| Carnitene 1.0 g/5.0 ml | 43716 | B | A16AA01 | 1983-07-13 |
| Ceclor 250 mg | 41720 | A | J01DC04 | 1978-11-02 |
| Clensia | 67326 | B | A06AD65 | 2019-10-03 |
| Eltroxin-LF | 29812 | B | H03AA01 | 1963-08-15 |
| Lodine 300 mg | 48625 | B | M01AB08 | 1987-12-10 |
| Lodine retard 600 mg | 51181 | B | M01AB08 | 1993-06-28 |
| Xifaxan 550 mg | 63216 | B | A07AA11 | 2015-03-19 |
Frequently asked questions
How many medicines does Alfasigma Schweiz AG have authorised in Switzerland?
Alfasigma Schweiz AG is recorded by Swissmedic as the authorisation holder for 11 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Alfasigma Schweiz AG based?
The Swiss location recorded for Alfasigma Schweiz AG is Zofingen, Aargau.
Is Alfasigma Schweiz AG a Swissmedic authorisation holder?
Yes. Alfasigma Schweiz AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.